| |
| Life Sciences |
| |
Since the human genome was decoded in 2001, our understanding of genetics has been revolutionised. This knowledge is now being translated into new drugs and diagnostic tools. Advances include:
Biochips
The demand for biochips and lab-on-chip (LOC) technology is growing massively as they help to streamline drug development procedures and find practical applications in numerous laboratory devices. More...
Cell-based assays
Offering a more accurate representation of real-life cell models than traditional enzyme or antibody-based assays, these are fast becoming essential tools for pharmaceutical, biotechnology and drug discovery companies. More...
|
|
|
|
|
| |
 |
Biomarkers
It costs US$1.7 billion to get a drug to market. Biomarkers are emerging as one of the main solutions for tackling escalating costs and lengthy clinical trials. More...
Downstream processing
The growth in biopharmaceutical production is forcing manufacturers to improve their downstream processes by using high-throughput membrane chromatography systems and integrated technology solutions. More...
RNAi
Ribonucleic acid interference (RNAi) is another new approach to drug discovery and much depends on scientists finding an efficient means of delivering it into target genes.
With over 15 years of experience in the sector, BCM’s communications experts are ideally placed to make sure that your company’s innovations reach the widest audience possible. More... |
|
|
